Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wellnex LifeASX:WNX -8.60% 3-Year EPS without NRI Growth Rate is 13.90% as of Dec. 2025, which is 25% below its 10-year median of 18.45. The stock has 2 warning signs investors should review. Among 1,524 Consumer Packaged Goods companies, Wellnex Life ranks better than 58.99% on this metric.
During the past 3 years, the average EPS without NRI Growth Rate was 13.90% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 30.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 9 years, the highest 3-Year average EPS without NRI Growth Rate of Wellnex Life was 46.20% per year. The lowest was -6.30% per year. And the median was 18.45% per year.
Wellnex Life (ASX:WNX) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Wellnex Life 3-Year EPS without NRI Growth Rate Related Terms
ASX:WNX vs KHC, GIS: 3-Year EPS without NRI Growth Rate Comparison
For the Packaged Foods subindustry, Wellnex Life's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wellnex Life 3-Year EPS without NRI Growth Rate vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Wellnex Life's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Wellnex Life's 3-Year EPS without NRI Growth Rate falls into.
Wellnex Life 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 13.90% mean?
Wellnex Life (ASX:WNX) has a 3-Year EPS without NRI Growth Rate of 13.90% as of Dec. 2025. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Wellnex Life and its competitors. This is 25% below median its historical median of 18.45. According to the industry distribution chart, Wellnex Life ranks #625 out of 1524 companies in the Consumer Packaged Goods industry, placing it in the top 41%.
Is Wellnex Life's 3-Year EPS without NRI Growth Rate too high?
Wellnex Life's current 3-Year EPS without NRI Growth Rate of 13.90% is 25% below median its 10-year median of 18.45. The Consumer Packaged Goods industry median 3-Year EPS without NRI Growth Rate is 7.40. Wellnex Life's value of 13.90% is 87.8% above this industry median. Based on the distribution chart, Wellnex Life ranks #625 out of 1524 companies in the Consumer Packaged Goods industry, which is above the industry midpoint.
How does Wellnex Life's 3-Year EPS without NRI Growth Rate compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Wellnex Life ranks #625 out of 1524 companies for 3-Year EPS without NRI Growth Rate. This puts Wellnex Life in the upper half of its industry. The industry median 3-Year EPS without NRI Growth Rate is 7.40. Wellnex Life's value of 13.90% is 87.8% above this benchmark. While the company's 10-year median is 18.45 vs. the industry median of 7.40, Wellnex Life has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EPS without NRI Growth Rate among Consumer Packaged Goods companies is 7.40, based on 1,524 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EPS without NRI Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Wellnex Life's current 3-Year EPS without NRI Growth Rate of 13.90% is 87.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Wellnex Life and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EPS without NRI Growth Rate is 7.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wellnex Life's current 3-Year EPS without NRI Growth Rate is 13.90%, which is 25% below median its own 10-year median of 18.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wellnex Life stock overvalued right now?
Based on GuruFocus' analysis, Wellnex Life (ASX:WNX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.36, compared to a current price of A$0.09 — trading 76.4% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 13.90%, which is 25% below median its 10-year median of 18.45 and 87.8% above the Consumer Packaged Goods industry median of 7.40. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Wellnex Life (ASX:WNX), the current 3-Year EPS without NRI Growth Rate is 13.90% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wellnex Life Ltd is a consumer healthcare company focused on developing, licensing, marketing, and distributing healthcare and pharmaceutical products. These products are available mainly through Australian retailers and wholesalers, including Coles, Woolworths, Chemist Warehouse, Sigma, and Symbion. The group's offerings include caffeine energy liquid capsules, multivitamins, pain relief creams and sprays, sleep aids, toothpaste, over-the-counter medicines, and medical cannabis products, among others. Its brands include Pharmacy Own, Wellness Life, Mr. Bright, Pain Away, Nighty Night, Wakey Wakey, and Wagner Health Liquigesic. Geographically, the majority of the group's revenue comes from Australia, with additional contributions from the United Kingdom and New Zealand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:WNX has been successfully added to your 
